Diametric Capital’s Medline Inc MDLN Stock Holding History

Diametric Capital’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,041	Closed	-$269K	–	757
2026 Q1	$269K	Sell	6,041 -889	-13%	-$39.3K	0.07%	355
2025 Q4	$291K	Buy	+6,930	New	+$293K	0.08%	303

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Diametric Capital's MDLN Position: Q2 2026 in Review

Diametric Capital sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 6,041 shares — an estimated $269K sold.

Diametric Capital first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $291K in Q4 2025. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Diametric Capital reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Diametric Capital sold 6,041 Medline Inc shares in Q2 2026, an estimated $269K.
Diametric Capital first reported a position in Medline Inc in Q4 2025 and held it in 2 quarters.
Diametric Capital's Medline Inc position peaked at $291K in Q4 2025.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.